INHIBITORS OF HISTONE DEACETYLASE FOR THE TREATMENT OF DISEASE
    4.
    发明申请
    INHIBITORS OF HISTONE DEACETYLASE FOR THE TREATMENT OF DISEASE 审中-公开
    用于治疗疾病的组织脱乙酰酶的抑制剂

    公开(公告)号:US20070135438A1

    公开(公告)日:2007-06-14

    申请号:US11608736

    申请日:2006-12-08

    CPC分类号: C07D213/76 C07D405/12

    摘要: Disclosed herein are carbonyl compounds of having the structural formula: or a pharmaceutically acceptable salt, ester, or prodrug thereof, Methods and compositions are disclosed for treating disease states including, but not limited to cancers, autoimmune diseases, tissue damage, central nervous system disorders, neurodegenerative disorders, fibrosis, bone disorders, polyglutamine-repeat disorders, anemias, thalassemias, inflammatory conditions, cardiovascular conditions, and disorders in which angiogenesis play a role in pathogenesis, using the compounds of the invention. In addition, methods of modulating the activity of histone deacetylase (HDAC) are also disclosed.

    摘要翻译: 本文公开了具有以下结构式的羰基化合物:或其药学上可接受的盐,酯或前药。公开了用于治疗疾病状态的方法和组合物,包括但不限于癌症,自身免疫疾病,组织损伤,中枢神经系统疾病 使用本发明的化合物,神经变性疾病,纤维化,骨病,聚谷氨酰胺重复病症,贫血,地热病,炎性病症,心血管病症和血管生成在发病机理中发挥作用的病症。 此外,还公开了调节组蛋白脱乙酰酶(HDAC)的活性的方法。

    Di-aryl substituted pyrazole modulators of metabotropic glutamate receptor-5
    5.
    发明申请
    Di-aryl substituted pyrazole modulators of metabotropic glutamate receptor-5 审中-公开
    代谢型谷氨酸受体-5的二芳基取代的吡唑调节剂

    公开(公告)号:US20060194807A1

    公开(公告)日:2006-08-31

    申请号:US10551709

    申请日:2004-03-30

    摘要: Novel pyrazole compounds such as compounds of the formula (I): (where A, A1, A2, B, R11, W, X, Y and Z are as defined herein) in which the pyrazole is substituted directly, or by a bridge, with i) a heteroaryl moiety containing N adjacent to the point of connection of the heteroaryl, and ii) another heteroaryl or aryl ring, with at least one of the rings being further substituted with another ring, are mGluR5 modulators useful in the treatment of psychiatric and mood disorders such as, for example, schizophrenia, anxiety, depression, panic, and bipolar disorder, as well as in the treatment of pain, Parkinson's disease, cognitive dysfunction, epilepsy, circadian rhythm disorders, obesity, drug addiction, drug abuse, drug withdrawal and other diseases.

    摘要翻译: 新的吡唑化合物,例如式(I)的化合物:其中A,A 1,A 2,B,R 11,W ,X,Y和Z如本文所定义),其中吡唑直接被取代,或通过桥取代,其中i)杂芳基部分含有与杂芳基的连接点相邻的N,和ii)另一个杂芳基或芳基环 ,其中至少一个环被另一个环取代,是用于治疗精神病和情绪障碍的mGluR5调节剂,例如精神分裂症,焦虑症,抑郁症,恐慌症和双相情感障碍,以及在 治疗疼痛,帕金森病,认知功能障碍,癫痫,昼夜节律紊乱,肥胖,药物成瘾,药物滥用,戒毒等疾病。

    SELF HEALING HIGH ENERGY GLASS CAPACITORS
    7.
    发明申请
    SELF HEALING HIGH ENERGY GLASS CAPACITORS 有权
    自我治疗高能量玻璃电容器

    公开(公告)号:US20110085279A1

    公开(公告)日:2011-04-14

    申请号:US12900976

    申请日:2010-10-08

    IPC分类号: H01G4/06

    CPC分类号: H01G4/105

    摘要: A self healing high energy glass capacitor is provided. The capacitor can have a glass layer with a top surface and a bottom surface. A top sacrificial layer can extend across the top surface and a bottom sacrificial layer can extend across the bottom surface. In addition, a top electrode can extend across the top sacrificial layer and a bottom electrode can extend across the bottom sacrificial layer. In some instances the glass capacitor has an energy breakdown of at least 6 joules per cubic centimeter.

    摘要翻译: 提供自愈高能玻璃电容器。 电容器可以具有顶表面和底表面的玻璃层。 顶部牺牲层可以跨越顶部表面延伸,并且底部牺牲层可延伸穿过底部表面。 此外,顶部电极可以跨越顶部牺牲层延伸,并且底部电极可延伸穿过底部牺牲层。 在一些情况下,玻璃电容器具有至少6焦耳/立方厘米的能量击穿。